Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 5/20 | 0.47 |
| ▸ | NPY4R | P50391 | 11/20 | 0.43 |
| ▸ | NPY1R | P25929 | 6/20 | 0.43 |
| ▸ | NPY2R | P49146 | 5/20 | 0.43 |
| ▸ | NPY5R | Q15761 | 5/20 | 0.43 |
| ▸ | FNTA | P49354 | 2/20 | 0.39 |
| ▸ | FNTB | P49356 | 2/20 | 0.39 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30730548 | 0.96 | NOD1 (0.47) | NOD1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL30516169 | 0.94 | NOD1 (0.41) | NOD1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL30140821 | 0.93 | NOD1 (0.50) | NOD1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL29568549 | 0.91 | NPY4R (0.47) | NOD1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL29779797 | 0.91 | NPY4R (0.48) | NOD1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL30121059 | 0.91 | NPY4R (0.48) | NOD1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL29887603 | 0.91 | NPY4R (0.48) | NOD1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL18660499 | 0.91 | NPY4R (0.48) | NOD1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL30120978 | 0.91 | NPY4R (0.48) | NOD1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL27632326 | 0.91 | NOD1 (0.51) | NOD1NPY4RNPY1RNPY2RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4314016-A1 | CYCLIC CELL PENETRATING PEPTIDES | Entrada Therapeutics, Inc. (US) | 2024-02-07 | — | — | EP | disclosed |
| WO-2022213118-A1 | CYCLIC CELL PENETRATING PEPTIDES | ENTRADA THERAPEUTICS, INC. (US) | 2022-10-06 | — | — | WO | disclosed |